Mobile

Maintenance treatment of anemia in pre-dialysis subjects with chronic kidney disease on darbepoetin treatment versus BAY 85-3934

Update Il y a 4 ans
Reference: EUCTR2013-001192-21

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of 16 weeks of titrated dose treatment with BAY 85 3934 versus darbepoetin alfa (hereafter called darbepoetin) as measured by haemoglobin (Hb) levels during the last 4 weeks of treatment (evaluation period).

Inclusion criteria

  • Anaemia of Chronic Kidney Disease

Links